Machine perfusion of thoracic organs.

This article summarizes recent knowledge and clinical advances in machine perfusion (MP) of thoracic organs. MP of thoracic organs has gained much attention during the last decade. Clinical studies are investigating the role of MP to preserve, resuscitate, and assess heart and lungs prior to transplantation. Currently, MP of the cardiac allograft is essential in all type DCD heart transplantation while MP of the pulmonary allograft is mandatory in uncontrolled DCD lung transplantation. MP of thoracic organs also offers an exciting platform to further investigate downregulation of the innate and adaptive immunity prior to reperfusion of the allograft in recipients. MP provides a promising technology that allows pre-transplant preservation, resuscitation, assessment, repair, and conditioning of cardiac and pulmonary allografts outside the body in a near physiologic state prior to planned transplantation. Results of ongoing clinical trials are awaited to estimate the true clinical value of this new technology in advancing the field of heart and lung transplantation by increasing the total number and the quality of available organs and by further improving recipient early and long-term outcome.

[1]  K. Shadan,et al.  Available online: , 2012 .

[2]  S. Germscheid,et al.  Ex vivo perfusion of the swine heart as a method for pre-transplant assessment , 2012, Perfusion.

[3]  P. Sanchez,et al.  Successful lung salvage by ex vivo reconditioning of neurogenic pulmonary edema: case report. , 2014, Transplantation proceedings.

[4]  S. Toyooka,et al.  Suppression of inflammatory cytokines during ex vivo lung perfusion with an adsorbent membrane. , 2010, The Annals of thoracic surgery.

[5]  P. Corris,et al.  The effect of ex vivo lung perfusion on microbial load in human donor lungs. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  D. Wishart,et al.  Metabolic Profile of Ex Vivo Lung Perfusate Yields Biomarkers for Lung Transplant Outcomes , 2018, Annals of surgery.

[7]  M. Mengel,et al.  A Leukocyte Filter Does Not Provide Further Benefit During Ex Vivo Lung Perfusion , 2017, ASAIO journal.

[8]  W. Wicomb,et al.  Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system. , 1984, The Annals of thoracic surgery.

[9]  J. Dyck,et al.  Negative pressure ventilation decreases inflammation and lung edema during normothermic ex-vivo lung perfusion. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  S. Russell,et al.  Report from a consensus conference on primary graft dysfunction after cardiac transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  J. Fildes,et al.  Clinical Outcome of Patients Transplanted with Marginal Donor Lungs via Ex Vivo Lung Perfusion Compared to Standard Lung Transplantation , 2015, Transplantation.

[12]  B. Leskosek,et al.  Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  V. Ranieri,et al.  Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[14]  R. Fisk,et al.  Ex vivo evaluation of stored lungs. , 1970, The Annals of thoracic surgery.

[15]  G. Remuzzi,et al.  Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation , 2010, Current opinion in organ transplantation.

[16]  F. Rega,et al.  Machine perfusion in organ transplantation: a tool for ex-vivo graft conditioning with mesenchymal stem cells? , 2013, Current opinion in organ transplantation.

[17]  S. Keshavjee,et al.  Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  L. Dembo,et al.  Successful Heart Transplant after Ten Hours Out-of-body Time using the TransMedics Organ Care System. , 2015, Heart, lung & circulation.

[19]  C. White,et al.  Donor heart preservation: straight up, or on the rocks? , 2015, The Lancet.

[20]  Alvaro Rojas-Pena,et al.  Achieving 12 Hour Normothermic Ex Situ Heart Perfusion: An Experience of 40 Porcine Hearts , 2016, ASAIO journal.

[21]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  Lars M. Mattison,et al.  Prolonged EVLP Using OCS Lung: Cellular and Acellular Perfusates , 2017, Transplantation.

[23]  P. Macdonald,et al.  Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series , 2015, The Lancet.

[24]  G. Verleden,et al.  Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model , 2017, Stem Cell Research & Therapy.

[25]  S. Keshavjee,et al.  Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  W. Klepetko,et al.  Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  S. Large,et al.  Resuscitating heart transplantation: the donation after circulatory determined death donor. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  W. Weder,et al.  Ex vivo treatment with inhaled N-acetylcysteine in porcine lung transplantation. , 2017, The Journal of surgical research.

[29]  J. Luketich,et al.  Targeting Circulating Leukocytes and Pyroptosis During Ex Vivo Lung Perfusion Improves Lung Preservation , 2017, Transplantation.

[30]  S. Khuri,et al.  Continuous perfusion of donor hearts in the beating state extends preservation time and improves recovery of function. , 1998, The Journal of thoracic and cardiovascular surgery.

[31]  B. Xiang,et al.  A whole blood-based perfusate provides superior preservation of myocardial function during ex vivo heart perfusion. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[32]  G. Dellgren,et al.  Hemofiltration in ex vivo lung perfusion-a study in experimentally induced pulmonary edema. , 2016, The Journal of thoracic and cardiovascular surgery.

[33]  Kristen M. Mackowick,et al.  Current state of ex-vivo lung perfusion , 2016, Current opinion in organ transplantation.

[34]  J. Madsen,et al.  Mid and Long-Term Clinical Results of OCS Lung INSPIRE International Trial , 2016 .

[35]  A. Neyrinck,et al.  Can we make recovered donor lungs look brand-new again? , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[36]  M. Matthay,et al.  Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors , 2011, Stem cells.

[37]  W. Wicomb,et al.  Twenty-four-hour preservation of the pig heart by a portable hypothermic perfusion system. , 1982, Transplantation.

[38]  S. Keshavjee,et al.  Extracorporeal lung perfusion (ex-vivo lung perfusion) , 2016, Current opinion in organ transplantation.

[39]  C. Salas,et al.  90 Clinical Lung Transplantation after Ex Vivo Evaluation of Uncontrolled Non Heart-Beating Donors Lungs: Initial Experience , 2011 .

[40]  B. Xiang,et al.  Physiologic Changes in the Heart Following Cessation of Mechanical Ventilation in a Porcine Model of Donation After Circulatory Death: Implications for Cardiac Transplantation , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  P. Johnsson,et al.  Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. , 2009, The Annals of thoracic surgery.

[42]  S. Keshavjee,et al.  Advances in lung preservation. , 2013, The Surgical clinics of North America.

[43]  M. Matthay,et al.  Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction following Trauma or Sepsis , 2016 .

[44]  F. Rosenfeldt,et al.  Low-flow hypothermic crystalloid perfusion is superior to cold storage during prolonged heart preservation. , 2014, Transplantation proceedings.

[45]  R. Hasan,et al.  Innovations in cardiac transplantation , 2017, Current opinion in cardiology.

[46]  J. Lally,et al.  An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK. , 2016, Health technology assessment.

[47]  P. Macdonald,et al.  Ex-vivo Donor Heart Perfusion: Testing the Limits of Cardiac Resilience. , 2015, Heart, lung & circulation.

[48]  W. Weder,et al.  Successful lung transplantation after donor lung reconditioning with urokinase in ex vivo lung perfusion system. , 2014, The Annals of thoracic surgery.

[49]  S. Keshavjee,et al.  Ex-vivo lung perfusion: the model for the organ reconditioning hub , 2017, Current opinion in organ transplantation.

[50]  K. English,et al.  Allogeneic mesenchymal stem cells: Agents of immune modulation , 2011, Journal of cellular biochemistry.

[51]  S. Steen,et al.  Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. , 2003, The Annals of thoracic surgery.

[52]  Marius Roman,et al.  Comparison between cellular and acellular perfusates for ex vivo lung perfusion in a porcine model. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[53]  Y. Dmitriev,et al.  Preservation of the donor heart: from basic science to clinical studies. , 2015, Interactive cardiovascular and thoracic surgery.

[54]  S. Keshavjee,et al.  Extending the donor pool: rehabilitation of poor organs. , 2015, Thoracic surgery clinics.

[55]  A. Fisher,et al.  Ex vivo lung perfusion in clinical lung transplantation--state of the art. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[56]  P. Macdonald,et al.  Extracorporeal heart perfusion before heart transplantation: the heart in a box , 2016, Current opinion in organ transplantation.

[57]  N. Fukushima Current status and future aspects of ex vivo allograft perfusion for heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[58]  S. Keshavjee,et al.  Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[59]  P. Vogt,et al.  Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[60]  H. Møller-Sørensen,et al.  First Danish experience with ex vivo lung perfusion of donor lungs before transplantation. , 2014, Danish medical journal.

[61]  G. Oniscu,et al.  Extending normothermic regional perfusion to the thorax in donors after circulatory death , 2017, Current opinion in organ transplantation.

[62]  S. Steen,et al.  Comparative outcome of double lung transplantation using conventional donor lungs and non-acceptable donor lungs reconditioned ex vivo. , 2011, Interactive cardiovascular and thoracic surgery.

[63]  S. Keshavjee,et al.  Extracorporeal lung perfusion , 2011, Current opinion in organ transplantation.

[64]  S. Keshavjee,et al.  Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[65]  Shaf Keshavjee,et al.  A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[66]  F. de Robertis,et al.  Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[67]  A. Poncelet,et al.  Hypothermic continuous machine perfusion enables preservation of energy charge and functional recovery of heart grafts in an ex vivo model of donation following circulatory death. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[68]  S. Steen,et al.  Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours , 2016, Scandinavian cardiovascular journal : SCJ.

[69]  M. Weiss,et al.  Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death , 2017, Respiratory Research.

[70]  V. Valero,et al.  Association Between Prolonged Graft Ischemia and Primary Graft Failure or Survival Following Lung Transplantation. , 2015, JAMA surgery.

[71]  F. de Robertis,et al.  Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile. , 2014, The Annals of thoracic surgery.

[72]  G. Warnecke Ex Vivo Treatment. , 2016, Transplantation.

[73]  G. Verleden,et al.  Preemptive therapy with steroids but not macrolides improves gas exchange in caustic-injured donor lungs. , 2011, The Journal of surgical research.

[74]  P. Jansz,et al.  Increasing the Tolerance of DCD Hearts to Warm Ischemia by Pharmacological Postconditioning , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[75]  J. Davies,et al.  Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[76]  S. Vesconi,et al.  Successful Transplantation of Lungs From an Uncontrolled Donor After Circulatory Death Preserved In Situ by Alveolar Recruitment Maneuvers and Assessed by Ex Vivo Lung Perfusion , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[77]  G. Tenderich,et al.  10: Prospective multi-center European trial to evaluate the safety and performance of the Organ Care System for heart transplants (PROTECT) , 2007 .

[78]  Utilization of the Organ Care System Lung for the assessment of lungs from a donor after cardiac death (DCD) before bilateral transplantation , 2015, Perfusion.

[79]  E. Ashley,et al.  Functional assessment and transplantation of the donor heart after circulatory death. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[80]  L. Santambrogio,et al.  Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation , 2014, Transplant international : official journal of the European Society for Organ Transplantation.

[81]  S. Keshavjee,et al.  α1-Anti-trypsin improves function of porcine donor lungs during ex-vivo lung perfusion. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[82]  H. Ott,et al.  Injury-specific ex vivo treatment of the donor lung: pulmonary thrombolysis followed by successful lung transplantation. , 2013, American journal of respiratory and critical care medicine.

[83]  Marcelo Cypel,et al.  Experience with the first 50 ex vivo lung perfusions in clinical transplantation. , 2012, The Journal of thoracic and cardiovascular surgery.

[84]  S. Keshavjee,et al.  The clinical potential of ex vivo lung perfusion , 2012, Expert review of respiratory medicine.

[85]  N. Perico,et al.  Mesenchymal stromal cells to promote solid organ transplantation tolerance , 2013, Current opinion in organ transplantation.

[86]  G. Dellgren,et al.  Comparison of two strategies for ex vivo lung perfusion. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[87]  F. D'Ovidio,et al.  Ex-vivo lung perfusion , 2012, Current opinion in organ transplantation.

[88]  S. Keshavjee,et al.  Normothermic Ex Vivo Perfusion Prevents Lung Injury Compared to Extended Cold Preservation for Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[89]  S. Keshavjee,et al.  Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study. , 2017, The Lancet. Respiratory medicine.

[90]  D. Valdivia,et al.  Clinical lung transplantation from uncontrolled non-heart-beating donors revisited. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[91]  B. Meyns,et al.  Current preservation technology and future prospects of thoracic organs. Part 2: heart , 2010, Current opinion in organ transplantation.

[92]  G. Dellgren,et al.  Transplantation after ex vivo lung perfusion: A midterm follow-up. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[93]  G. Verleden,et al.  A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury , 2017, Medical gas research.

[94]  A. Ardehali,et al.  19: Serum Lactate Is a Highly Sensitive and Specific Predictor of Post Cardiac Transplant Outcomes Using the Organ Care System , 2009 .

[95]  B. Griffith,et al.  The NOVEL Lung Trial One-Year Outcomes , 2014 .

[96]  A. Haverich,et al.  Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients , 2012, The Lancet.

[97]  D. Foley,et al.  Safety of Antithymocyte Globulin in Patients Undergoing Liver Transplantation With Livers From Donation After Circulatory Death Donors , 2019, The Annals of pharmacotherapy.

[98]  A. Ardehali,et al.  Normothermic donor heart perfusion: current clinical experience and the future , 2015, Transplant international : official journal of the European Society for Organ Transplantation.

[99]  P. Dartevelle,et al.  Graft ischemic time and outcome of lung transplantation: a multicenter analysis. , 2005, American journal of respiratory and critical care medicine.

[100]  T. Frauenfelder,et al.  Cytokine filtration modulates pulmonary metabolism and edema formation during ex vivo lung perfusion. , 2016, The Journal of Heart and Lung Transplantation.

[101]  A. Rose,et al.  Forty-eight hours hypothermic perfusion storage of pig and baboon hearts. , 1986, The Journal of surgical research.

[102]  L. Liaudet,et al.  Pharmacological Reconditioning of Marginal Donor Rat Lungs Using Inhibitors of Peroxynitrite and Poly (ADP-ribose) Polymerase During Ex Vivo Lung Perfusion , 2016, Transplantation.

[103]  A. Simon,et al.  Ex vivo heart perfusion after cardiocirculatory death; a porcine model. , 2015, The Journal of surgical research.

[104]  B. Xiang,et al.  Hearts From DCD Donors Display Acceptable Biventricular Function After Heart Transplantation in Pigs , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[105]  S. Keshavjee,et al.  The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[106]  J. Luketich,et al.  Optimal ex vivo lung perfusion techniques with oxygenated perfusate. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[107]  J. Luc,et al.  Lung transplantation from donors after circulatory death using portable ex vivo lung perfusion. , 2015, Canadian respiratory journal.

[108]  Christoph Benk,et al.  Ex vivo perfusion of the heart with the use of the Organ Care System. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[109]  P. Jansz,et al.  Normothermic Ex Vivo Perfusion Provides Superior Organ Preservation and Enables Viability Assessment of Hearts From DCD Donors , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[110]  G. Verleden,et al.  Radiological Analysis of Unused Donor Lungs: A Tool to Improve Donor Acceptance for Transplantation? , 2017, American Journal of Transplantation.

[111]  S. Keshavjee,et al.  Importance of left atrial pressure during ex vivo lung perfusion. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[112]  N. Perico,et al.  Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). , 2010, Transplantation.

[113]  W. S. Ring,et al.  Perfusion preservation versus static preservation for cardiac transplantation: effects on myocardial function and metabolism. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[114]  Michael John Smith,et al.  The OCS Lung EXPAND International Trial Interim Results , 2016 .

[115]  G. Lang,et al.  Clinical Ex Vivo Lung Perfusion—Pushing the Limits , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[116]  P. Macdonald,et al.  Heart transplantation from donation after circulatory death donors. , 2015, Transplantation.

[117]  Marcelo Cypel,et al.  Normothermic ex vivo lung perfusion in clinical lung transplantation. , 2011, The New England journal of medicine.

[118]  S. Keshavjee,et al.  Lung Transplantation With Donation After Circulatory Determination of Death Donors and the Impact of Ex Vivo Lung Perfusion , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[119]  E. Proctor,et al.  Preservation of Isolated Heart for 72 Hours , 1968, British medical journal.

[120]  J. Kobashigawa,et al.  Intermediate outcomes with ex-vivo allograft perfusion for heart transplantation. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[121]  Amadou K. S. Camara,et al.  Low-flow perfusion of guinea pig isolated hearts with 26 degrees C air-saturated Lifor solution for 20 hours preserves function and metabolism. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[122]  W. Weimar,et al.  Mesenchymal stem cells: application for solid-organ transplantation , 2012, Current opinion in organ transplantation.

[123]  V. Puri,et al.  Lung transplantation from donation after cardiocirculatory death: a systematic review and meta-analysis. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[124]  B. Griffith,et al.  Heart preservation using continuous ex vivo perfusion improves viability and functional recovery. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[125]  F. Mohr,et al.  Functional, metabolic, and morphological aspects of continuous, normothermic heart preservation: effects of different preparation and perfusion techniques. , 2009, Tissue engineering. Part C, Methods.

[126]  M. Stoler,et al.  Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism , 2017, The Journal of thoracic and cardiovascular surgery.

[127]  Bartley P Griffith,et al.  State of art: clinical ex vivo lung perfusion: rationale, current status, and future directions. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[128]  S. Keshavjee,et al.  Ex Vivo Perfusion Treatment of Infection in Human Donor Lungs , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[129]  M. Ochs,et al.  Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours , 2016, Transplant international : official journal of the European Society for Organ Transplantation.

[130]  G. Tenderich,et al.  Normothermic ex vivo allograft blood perfusion in clinical heart transplantation. , 2014, The heart surgery forum.

[131]  Simi Ali,et al.  The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[132]  P. Dartevelle,et al.  Lung transplantation from initially rejected donors after ex vivo lung reconditioning: the French experience. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[133]  W. Weder,et al.  Ex vivo administration of trimetazidine improves post-transplant lung function in pig model† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[134]  S. Steen,et al.  Transplantation of lungs from a non-heart-beating donor , 2001, The Lancet.

[135]  G. Verleden,et al.  A retrospective database analysis to evaluate the potential of ex vivo lung perfusion to recruit declined lung donors , 2017, Transplant international : official journal of the European Society for Organ Transplantation.

[136]  G. Snell,et al.  How can we improve the quality of transplantable lungs? , 2016, Expert review of respiratory medicine.

[137]  G. Verleden,et al.  Short- and Long-term Outcomes After Lung Transplantation From Circulatory-Dead Donors: A Single-Center Experience , 2017, Transplantation.

[138]  Pascal Leprince,et al.  Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial , 2015, The Lancet.

[139]  L. M. Anderson,et al.  Preservation of donor hearts using hypothermic oxygenated perfusion. , 2014, Annals of transplantation.

[140]  Marius Roman,et al.  Ex vivo lung perfusion: a comprehensive review of the development and exploration of future trends. , 2013, Transplantation.

[141]  G. Dellgren,et al.  Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[142]  P. Macdonald,et al.  Donation after circulatory death heart transplantation , 2017, Current opinion in organ transplantation.

[143]  P. White,et al.  Cardiac recovery in a human non-heart-beating donor after extracorporeal perfusion: source for human heart donation? , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[144]  V. Puri,et al.  International Society for Heart and Lung Transplantation Donation After Circulatory Death Registry Report. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[145]  G. Dellgren,et al.  Transplantation of initially rejected donor lungs after ex vivo lung perfusion. , 2012, The Journal of thoracic and cardiovascular surgery.

[146]  F. de Robertis,et al.  Utilization of the organ care system for bilateral lung transplantation: preliminary results of a comparative study. , 2016, Interactive cardiovascular and thoracic surgery.

[147]  Triin Major,et al.  Altered Immunogenicity of Donor Lungs via Removal of Passenger Leukocytes Using Ex Vivo Lung Perfusion , 2015, American Journal of Transplantation.

[148]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[149]  J. Pirenne Time to think out of the (ice) box. , 2010, Current opinion in organ transplantation.

[150]  M. Rojas,et al.  Ex Vivo Lung Perfusion: Past, Present, and Future , 2017, ASAIO journal.

[151]  Arthur S Slutsky,et al.  Functional Repair of Human Donor Lungs by IL-10 Gene Therapy , 2009, Science Translational Medicine.

[152]  P. Bonnette,et al.  Real-Time Computed Tomography Highlights Pulmonary Parenchymal Evolution During Ex Vivo Lung Reconditioning. , 2017, The Annals of thoracic surgery.

[153]  M. Hannan,et al.  The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[154]  Stefan Fischer,et al.  Technique for prolonged normothermic ex vivo lung perfusion. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[155]  S. Keshavjee,et al.  Update on donor assessment, resuscitation, and acceptance criteria, including novel techniques--non-heart-beating donor lung retrieval and ex vivo donor lung perfusion. , 2009, Thoracic surgery clinics.

[156]  M. Hoogduijn,et al.  The impact of mesenchymal stem cell therapy in transplant rejection and tolerance , 2012, Current opinion in organ transplantation.

[157]  H. Date,et al.  Bronchodilator Inhalation During Ex Vivo Lung Perfusion Improves Posttransplant Graft Function After Warm Ischemia. , 2017, The Annals of thoracic surgery.

[158]  B. Xiang,et al.  A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[159]  B. Griffith,et al.  Autoperfusion of the heart and lungs for preservation during distant procurement. , 1987, The Journal of thoracic and cardiovascular surgery.